HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatsuya Sugawara Selected Research

Glucosamine (Dona)

2/2010Effect of glucosamine and related compounds on the degranulation of mast cells and ear swelling induced by dinitrofluorobenzene in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatsuya Sugawara Research Topics

Disease

9Inflammation (Inflammations)
10/2021 - 02/2010
7Neoplasms (Cancer)
06/2020 - 04/2005
7Colonic Neoplasms (Colon Cancer)
10/2018 - 12/2006
5Obesity
06/2020 - 01/2018
5Leukemia
06/2014 - 10/2009
3Non-alcoholic Fatty Liver Disease
01/2020 - 01/2011
2Insulin Resistance
01/2022 - 01/2012
2Fatty Liver
01/2020 - 01/2011
2Atherosclerosis
01/2020 - 05/2013
2Cardiovascular Diseases (Cardiovascular Disease)
05/2013 - 12/2006
2Hypertrophy
01/2011 - 01/2011
1Niemann-Pick Diseases (Niemann Pick Disease)
01/2022
1Body Weight (Weight, Body)
03/2015
1Vascular Diseases (Vascular Disease)
05/2013
1Atopic Dermatitis (Atopic Eczema)
06/2012
1Type 2 Diabetes Mellitus (MODY)
01/2012
1Contact Dermatitis (Eczema, Contact)
01/2011
1Osteoarthritis
02/2010
1Hypersensitivity (Allergy)
10/2009
1Colorectal Neoplasms (Colorectal Cancer)
04/2007
1Melanoma (Melanoma, Malignant)
01/2007
1Adenocarcinoma of Lung
03/2004
1Prostatic Neoplasms (Prostate Cancer)
02/2004

Drug/Important Bio-Agent (IBA)

13Carotenoids (Carotene)IBA
10/2021 - 02/2004
10siphonaxanthinIBA
06/2020 - 12/2010
6SphingolipidsIBA
01/2017 - 12/2006
4CeramidesIBA
01/2022 - 06/2012
4fucoxanthinIBA
10/2018 - 02/2004
4Glucosylceramides (Glucocerebrosides)IBA
01/2013 - 01/2011
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2012
2SphingomyelinsIBA
01/2022 - 06/2012
2CholesterolIBA
01/2020 - 03/2004
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2015
2Messenger RNA (mRNA)IBA
01/2020 - 01/2015
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2019 - 05/2013
2ChitosanIBA
10/2018 - 02/2010
2AntigensIBA
01/2014 - 10/2009
2peridininIBA
03/2009 - 04/2007
2CerebrosidesIBA
01/2007 - 12/2006
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2022
1Phosphorylcholine (Phosphocholine)IBA
01/2022
1Adiponectin ReceptorsIBA
01/2022
1LipidsIBA
01/2022
1AdipokinesIBA
01/2022
1AdiponectinIBA
01/2022
1AntioxidantsIBA
01/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1Advanced Glycation End ProductsIBA
01/2020
1Arachidonic Acid (Vitamin F)IBA
01/2019
110-hydroxy-cis-12-octadecenoic acidIBA
01/2019
1Nonesterified Fatty Acids (NEFA)IBA
01/2019
1Linoleic Acid (Linoleate)IBA
01/2019
1GlycolipidsIBA
10/2018
1CaspasesIBA
10/2018
1MagnesiumIBA
06/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2015
1Thymic Stromal LymphopoietinIBA
01/2015
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2015
1Angiogenesis InhibitorsIBA
08/2013
1Sterol Regulatory Element Binding Protein 1IBA
05/2013
1Eicosapentaenoic AcidIBA
05/2013
1EnzymesIBA
06/2012
1Insulin (Novolin)FDA Link
01/2012
1Monounsaturated Fatty AcidsIBA
01/2011
1Orotic AcidIBA
01/2011
1DinitrofluorobenzeneIBA
01/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2011
1Thiobarbituric Acid Reactive SubstancesIBA
01/2011
1Immunoglobulin E (IgE)IBA
02/2010
1ChitinIBA
02/2010
1Glucosamine (Dona)IBA
02/2010
1AcetylglucosamineIBA
02/2010
1astaxanthine (astaxanthin)IBA
10/2009
1beta-N-AcetylhexosaminidasesIBA
10/2009
1ZeaxanthinsIBA
10/2009
1beta Carotene (Betacarotene)FDA Link
10/2009
1Melanins (Melanin)IBA
01/2007
1HDL CholesterolIBA
12/2006
1Trans Fatty AcidsIBA
12/2006
1LDL CholesterolIBA
12/2006
1AnticoagulantsIBA
04/2005
1fucoidanIBA
04/2005
1PolymersIBA
04/2005
1FucoseIBA
04/2005
1Biological ProductsIBA
04/2005
17alpha- ethoxy- 3beta- hydroxy- 5alpha- B- homo- 6- oxacholestane- 5- hydroperoxideIBA
03/2004
1amarouciaxanthin AIBA
02/2004
1fucoxanthinolIBA
02/2004

Therapy/Procedure

3Therapeutics
08/2013 - 12/2010